DLP PHARMA Trademark

Trademark Overview

On Thursday, September 23, 2021, a trademark application was filed for DLP PHARMA with the United States Patent and Trademark Office. The USPTO has given the DLP PHARMA trademark a serial number of 97041581. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, November 4, 2024. The DLP PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Dietary and nutritional supplements; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension
dlp pharma

General Information

Serial Number97041581
Word MarkDLP PHARMA
Filing DateThursday, September 23, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, November 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2022

Trademark Statements

Goods and ServicesDietary and nutritional supplements; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension
NOT AVAILABLE"PHARMA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 25, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressMexico City 04010
MX
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressMexico City 04010
MX

Trademark Events

Event DateEvent Description
Monday, September 27, 2021NEW APPLICATION ENTERED
Monday, October 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, May 15, 2022ASSIGNED TO EXAMINER
Tuesday, May 17, 2022NON-FINAL ACTION WRITTEN
Tuesday, May 17, 2022NON-FINAL ACTION E-MAILED
Tuesday, May 17, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 9, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 9, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 10, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 20, 2022PUBLISHED FOR OPPOSITION
Tuesday, December 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 14, 2023SOU TEAS EXTENSION RECEIVED
Monday, August 14, 2023SOU EXTENSION 1 FILED
Monday, August 14, 2023SOU EXTENSION 1 GRANTED
Wednesday, August 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 26, 2024SOU TEAS EXTENSION RECEIVED
Friday, January 26, 2024SOU EXTENSION 2 FILED
Thursday, February 8, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 8, 2024SOU EXTENSION 2 GRANTED
Friday, June 28, 2024SOU TEAS EXTENSION RECEIVED
Friday, February 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 28, 2024SOU EXTENSION 3 FILED
Friday, June 28, 2024SOU EXTENSION 3 GRANTED
Monday, November 4, 2024SOU TEAS EXTENSION RECEIVED
Monday, November 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 4, 2024SOU EXTENSION 4 GRANTED
Monday, November 4, 2024SOU EXTENSION 4 FILED

Related Keywords

pharma treating preparations pharmaceutical hypertension diabetes nutritional supplements dietary